Finance

Lists
Why is NH down 2,01%?
Dive Deeper
NH:NSE
Նարայանա Հրուդայալայա
1 685,00 ₹
-2,01%
(-34,50) 1D
12 հոկ, 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NH...
Open
1 724,40 ₹
High
1 731,80 ₹
Low
1 682,00 ₹
Mkt. cap
342,22 մլրդ
Avg. vol.
216,03 հզր
Volume
128,15 հզր
Dividend
0,27%
Quarterly dividend
1,12 ₹
Ex-dividend date
17 հլս, 2026 թ.
P/E ratio
41,89
52-wk high
2 093,30 ₹
52-wk low
1 589,00 ₹
EPS
40,22 ₹
Shares outstanding
204,36 մլն
No. of employees
11 հզր
Open
1 724,40 ₹
High
1 731,80 ₹
Low
1 682,00 ₹
Mkt. cap
342,22 մլրդ
Avg. vol.
216,03 հզր
Volume
128,15 հզր
Dividend
0,27%
Quarterly dividend
1,12 ₹
Ex-dividend date
17 հլս, 2026 թ.
P/E ratio
41,89
52-wk high
2 093,30 ₹
52-wk low
1 589,00 ₹
EPS
40,22 ₹
Shares outstanding
204,36 մլն
No. of employees
11 հզր
News stories
From web sources and news partners
Profile
Narayana Health is an Indian for-profit private hospital network headquartered in Bangalore. It was founded by Dr. Devi Shetty in the year 2000. It operates several hospitals and heart centres across major Indian cities Bangalore, Delhi, Gurugram, Kolkata, Ahmedabad, Raipur, Jaipur, Mumbai, Mysore etc. with an international subsidiary in the Cayman Islands. The facilities offer medical care in over 30 medical specialties and three of its hospitals – Narayana Institute of Cardiac Sciences, Bangalore, and Health City Cayman Islands – are JCI accredited. Wikipedia
About Նարայանա Հրուդայալայա
CEOEmmanuel Rupert
Employees11,2 հզր
Founded2000
HeadquartersԲանգալոր, Կառնատակա, Հնդկաստան
SectorHealth care provider
Last report
03 օգս, 2026 թ.
Fiscal period
Q1 2027
10,20 ₹ / 11,93 ₹
-14,53%miss
Revenue / Est. (INR)
26,84 մլրդ / 26,38 մլրդ
+1,74%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
16,44 մլրդ
21,51 մլրդ
25,94 մլրդ
26,84 մլրդ
Cost of goods sold
8,76 մլրդ
11,99 մլրդ
18,24 մլրդ
15,66 մլրդ
Cost of revenue
8,76 մլրդ
11,99 մլրդ
18,24 մլրդ
15,66 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
2,56 մլրդ
-
Operating expense
4,53 մլրդ
7,07 մլրդ
4,14 մլրդ
8,04 մլրդ
Total operating expenses
13,29 մլրդ
19,06 մլրդ
22,38 մլրդ
23,70 մլրդ
Operating income
3,15 մլրդ
2,45 մլրդ
3,56 մլրդ
3,14 մլրդ
Other non operating income
239,92 մլն
232,06 մլն
-498,95 մլն
354,76 մլն
EBT including unusual items
2,95 մլրդ
1,50 մլրդ
2,92 մլրդ
2,60 մլրդ
EBT excluding unusual items
2,95 մլրդ
2,01 մլրդ
2,80 մլրդ
2,60 մլրդ
Income tax expense
371,93 մլն
222,70 մլն
641,07 մլն
531,19 մլն
Effective tax rate
12,59%
14,81%
21,94%
20,40%
Other operating expenses
3,65 մլրդ
5,85 մլրդ
38,10 մլն
6,48 մլրդ
Net income
2,58 մլրդ
1,27 մլրդ
2,24 մլրդ
2,07 մլրդ
Net profit margin
15,72%
5,89%
8,63%
7,72%
Earnings per share
12,71
8,45
11,22
10,20
Interest and investment income
-
-
594,31 մլն
-
Interest expense
-422,60 մլն
-650,33 մլն
-912,85 մլն
-868,01 մլն
Net interest expenses
-422,60 մլն
-650,33 մլն
-318,54 մլն
-868,01 մլն
Depreciation and amortization charges
874,76 մլն
1,22 մլրդ
1,54 մլրդ
1,56 մլրդ
EBITDA
4,01 մլրդ
3,01 մլրդ
4,45 մլրդ
4,03 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps